The threat of the omicron variant is becoming real for many of Asia’s biggest countries just as it looks set to subside in some Western nations, and that’s complicating investors’ search for winning share bets in the region.
The problem is that Asian governments are carrying out widely diverging coronavirus policies, with strategies ranging from China’s pursuit of "COVID zero" to Australia’s move to live with the virus, and almost everything in between. The speed of vaccinations and the strength of health care systems also vary greatly in the region.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
We humbly apologize for the inconvenience.